Martin Werner

1.1k total citations
21 papers, 837 citations indexed

About

Martin Werner is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Martin Werner has authored 21 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Martin Werner's work include Cancer, Lipids, and Metabolism (3 papers), Renal cell carcinoma treatment (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Martin Werner is often cited by papers focused on Cancer, Lipids, and Metabolism (3 papers), Renal cell carcinoma treatment (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Martin Werner collaborates with scholars based in Germany, Austria and Israel. Martin Werner's co-authors include M. Hohenegger, Axel Walch, Julia Sacher, Heinz Höfler, Silke Laßmann, Horst Zitzelsberger, Michaela Aubele, G. Gitsch, Csaba Szegedi and Lukas Weigl and has published in prestigious journals such as Journal of Clinical Oncology, American Journal Of Pathology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Martin Werner

18 papers receiving 819 citations

Peers

Countries citing papers authored by Martin Werner

Since Specialization

Citations

This map shows the geographic impact of Martin Werner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Werner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Werner more than expected).

Fields of papers citing papers by Martin Werner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Werner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Werner. The network helps show where Martin Werner may publish in the future.

Co-authorship network of co-authors of Martin Werner

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Werner. A scholar is included among the top collaborators of Martin Werner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Werner. Martin Werner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Can PSMA PET detect intratumour heterogeneity in histological PSMA expression of primary prostate cancer? Analysis of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 2025 ·European Journal of Nuclear Medicine and Molecular Imaging ·P Waibel, (unknown), Tobias Fechter, Michael Mix, (unknown), August Sigle, Cordula A. Jilg, Christian Gratzke, Martin Werner, Oliver Schilling, Peter Bronsert, Martin T. Freitag, Constantinos Zamboglou, Anca-Ligia Grosu, Simon K. B. Spohn	3
2	The Ectonucleotidases CD39 and CD73 and the Purinergic Receptor P2X4 Serve as Prognostic Markers in Non-Small Cell Lung Cancer 2025 ·Cancers ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Bernward Passlick, Martin Werner, Peter Bronsert, Severin Schmid	0
3	Improving outcomes in gyneco-oncology in late and last line setting: Real-world data from the molecular tumor board registry trial at the Comprehensive Cancer Center Freiburg (Germany). 2025 ·Journal of Clinical Oncology ·(unknown), Johannes Jung, Patrick Metzger, (unknown), (unknown), (unknown), Julia Kühn, (unknown), (unknown), Thalia Erbes, Silke Laßmann, (unknown), Cornelius Miething, Heiko Becker, (unknown), Martin Werner, Florin‐Andrei Taran, Justus Duyster, Melanie Boerries, Anna Lena Illert	0
4	Primary Results of Patients with Genitourinary Malignancies Presented at a Molecular Tumor Board 2024 ·Urologia Internationalis ·(unknown), (unknown), Patrick Metzger, (unknown), (unknown), Martin Werner, Cornelius Miething, (unknown), Anna Lena Illert, (unknown), (unknown), August Sigle, Christian Gratzke, Markus Grabbert	0
5	Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist ⁶⁸Ga-RM2 And PET 2016 ·Theranostics ·C. Stoykow, Thalia Erbes, Helmut R. Maëcke, Stefan Bulla, Mark Bartholomä, Sebastian Mayer, Vanessa Drendel, Peter Bronsert, Martin Werner, G. Gitsch, Wolfgang Weber, Elmar Stickeler, Philipp T. Meyer	96
6	In vitro and in vivo downregulation of the ATP binding cassette transporter B1 by the HMG-CoA reductase inhibitor simvastatin 2015 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·(unknown), Evelyn Berger–Sieczkowski, (unknown), Martin Werner, M. Hohenegger	19
7	Autosomal Dominant Polycystic Kidney Disease: Prevalence of Renal Neoplasias in Surgical Kidney Specimens 2013 ·Nephron Clinical Practice ·Cordula A. Jilg, Vanessa Drendel, (unknown), Przemyslaw Pisarski, Hannes Neeff, Oliver Drognitz, (unknown), Sven Gläsker, Angelica Malinoc, Zoran Erlic, Mercedes Núñez, (unknown), Pablo Javier Azurmendi, Wolfgang Schultze‐Seemann, Martin Werner, Hartmut P.H. Neumann	56
8	Simvastatin-induced compartmentalisation of doxorubicin sharpens up nuclear topoisomerase II inhibition in human rhabdomyosarcoma cells 2013 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Martin Werner, (unknown), Evelyn Berger–Sieczkowski, Peter Chiba, M. Hohenegger	17
9	Arterial dissections in autosomal dominant polycystic kidney disease – chance association or part of the disease spectrum? 2010 ·Clinical Nephrology ·(unknown), Martin Werner, Eliezer Golan, Z. Korzets	7
10	Multiple aetiologies of secondary hypertension in one patient 2008 ·Clinical Kidney Journal ·Eliezer Golan, Dan Nabriski, Yehonatan Sharabi, Martin Werner, (unknown), (unknown), Z. Korzets	1
11	STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation 2007 ·Journal of Clinical Pathology ·Silke Laßmann, Ingrid Schuster, Axel Walch, Heike Göbel, Uta Jütting, Frank Makowiec, Ulrich T. Hopt, Martin Werner	99
12	[Aurora-a is a predictive marker for stage III epithelial ovarian cancers]. 2007 ·PubMed ·Silke Laßmann, Yan Shen, Uta Jütting, (unknown), Axel Walch, G. Gitsch, Annette Hasenburg, Martin Werner	2
13	DNA topoisomerase IIα and Her-2/neu gene dosages in pediatric malignant gliomas 2005 ·International Journal of Oncology ·Claudia Bredel, Silke Laßmann, Ian F. Pollack, Rolf Knoth, (unknown), Benedikt Volk, Martin Werner, Markus Bredel	1
14	Delineation of Myotoxicity Induced by 3-Hydroxy-3-methylglutaryl CoA Reductase Inhibitors in Human Skeletal Muscle Cells 2005 ·Journal of Pharmacology and Experimental Therapeutics ·Julia Sacher, Lukas Weigl, Martin Werner, Csaba Szegedi, M. Hohenegger	82
15	Mutual amplification of apoptosis by statin‐induced mitochondrial stress and doxorubicin toxicity in human rhabdomyosarcoma cells 2004 ·British Journal of Pharmacology ·Martin Werner, Julia Sacher, M. Hohenegger	65
16	TO-PRO-3 is an optimal fluorescent dye for nuclear counterstaining in dual-colour FISH on paraffin sections 2001 ·Histochemistry and Cell Biology ·Karin Bink, Axel Walch, Annette Feuchtinger, Heinrich Eisenmann, Peter Hutzler, Heinz Höfler, Martin Werner	43
17	Chromosomal Imbalances in Barrett's Adenocarcinoma and the Metaplasia-Dysplasia-Carcinoma Sequence 2000 ·American Journal Of Pathology ·Axel Walch, Horst Zitzelsberger, Jochen Bruch, Gisela Keller, (unknown), Michaela Aubele, James Mueller, H. J. Stein, Herbert Braselmann, (unknown), Heinz Höfler, Martin Werner	130
18	Accumulation of Chromosomal Imbalances From Intraductal Proliferative Lesions to Adjacent In Situ and Invasive Ductal Breast Cancer 2000 ·Diagnostic Molecular Pathology ·Michaela Aubele, Margaret C. Cummings, A. Mattis, Horst Zitzelsberger, Axel Walch, Markus Kremer, Heinz Höfler, Martin Werner	49
19	Genetic heterogeneity in a prostatic carcinoma and associated prostatic intraepithelial neoplasia as demonstrated by combined use of laser-microdissection, degenerate oligonucleotide primed PCR and comparative genomic hybridization 1998 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Horst Zitzelsberger, Ulrike Kulka, (unknown), Axel Walch, Jan Smida, Michaela Aubele, Thomas Lörch, Heinz Höfler, Manfred Bauchinger, Martin Werner	60
20	Human monoclonal antibodies directed against ovarian carcinoma 1989 ·Gynecologic Oncology ·Martin Werner, T. Ahlert, G. Bastert	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact